Nova Tina Susan Insider Trades

Insider Trading History

Track insider trading activity for Nova Tina Susan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Azenta
Azenta AZTA
Director
Holding Value $360k 15,772 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 5,663 shares
$27.85
$22.84
Exagen
Exagen XGN
Director
Holding Value $64.7k 13,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.4k 13,500 shares
$7.36
$4.79
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $1.04M 63,724 shares
Last Trade
May 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$519k 63,724 shares
$8.15
$16.37
Azenta
Azenta AZTA
Director
Holding Value $231k 10,109 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$211k 4,040 shares
$52.32
$22.84
Exagen
Exagen XGN
Director
Holding Value $64.7k 13,500 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 13,500 shares
$1.99
$4.79
Azenta
Azenta AZTA
Director
Holding Value $139k 6,069 shares
Last Trade
Feb 12, 2024 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 2,465 shares
$65.93
$22.84
Exagen
Exagen XGN
Executive Chairperson
Holding Value $64.7k 13,500 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.5k 13,500 shares
$3.22
$4.79
Azenta
Azenta AZTA
Director
Holding Value $82.3k 3,604 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 3,604 shares
$45.09
$22.84
Exagen
Exagen XGN
Director
Holding Value $43.1k 9,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 9,000 shares
$5.25
$4.79
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $0 0 shares
Last Trade
Mar 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$720k 7,202 shares
$99.99
$99.99
Veracyte
Veracyte VCYT
President, CLIA U.s.
Holding Value $3.84M 76,988 shares
Last Trade
Mar 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 56,546 shares
$26.02
$49.94
Veracyte
Veracyte VCYT
President, CLIA U.s.
Holding Value $1.02M 20,442 shares
Last Trade
Mar 02, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$298k 10,695 shares
$27.84
$49.94
Veracyte
Veracyte VCYT
President, CLIA U.s.
Holding Value $1.5M 30,000 shares
Last Trade
Jan 06, 2022 Sale
$1.58M 45,000 shares
$35.12
$49.94
Exagen
Exagen XGN
Director
Holding Value $43.1k 9,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 9,000 shares
$16.41
$4.79
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $1.96M 19,643 shares
Last Trade
Jun 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$669k 10,269 shares
$65.19
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $3.39M 33,876 shares
Last Trade
Aug 26, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.18M 17,300 shares
$68.16
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $1.66M 16,576 shares
Last Trade
Aug 26, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.18M 17,300 shares
$67.94
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $0 0 shares
Last Trade
Aug 26, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.18M 17,300 shares
$68.16
$99.99
Exagen
Exagen XGN
Director
Holding Value $43.1k 9,000 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 9,000 shares
$13.00
$4.79
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Director
Holding Value $1.66M 16,576 shares
Last Trade
Jun 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 7,446 shares
$61.31
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up